A hepatic function panel is a blood test that checks several liver-related markers at the same time. It usually includes liver enzymes, bilirubin, albumin, total protein, and sometimes direct bilirubin or an albumin/globulin ratio. The panel can show signs of liver cell irritation, bile duct blockage, reduced protein production, medication effects, alcohol-related injury, fatty liver disease, hepatitis, or other liver and gallbladder problems. It does not diagnose one condition by itself. The pattern matters more than any single number.
Many abnormal results are mild and temporary, especially after a recent illness, alcohol use, hard exercise, or a new medication. Other patterns need prompt follow-up, especially when abnormal liver enzymes appear with jaundice, dark urine, pale stools, confusion, severe abdominal pain, easy bleeding, or a high INR. A hepatic function panel is most useful when it is interpreted with symptoms, medical history, medication and supplement use, and repeat testing when needed.
- A hepatic function panel usually measures ALT, AST, ALP, bilirubin, albumin, total protein, and sometimes direct bilirubin or an A/G ratio.
- High ALT and AST usually point toward liver cell injury, while high ALP with bilirubin can suggest bile duct or cholestatic disease.
- Low albumin can reflect reduced liver protein production, but kidney disease, inflammation, malnutrition, and protein loss can also lower it.
- Normal ranges vary by lab, age, sex, pregnancy status, and testing method, so compare results with the reference range on your report.
- Urgent care matters when abnormal liver tests occur with jaundice, confusion, severe right upper abdominal pain, vomiting, fever, bleeding, or extreme weakness.
Table of Contents
- What the Hepatic Function Panel Measures
- Normal Ranges and What Counts as Abnormal
- How to Read Liver Enzyme Patterns
- Bilirubin, Albumin, and Protein Results
- Common Causes of Abnormal Results
- Preparation, Repeat Testing, and Follow-Up
- When Results Need Urgent Care
- How the Panel Fits With Other Liver Tests
What the Hepatic Function Panel Measures
A hepatic function panel, also called a liver panel or liver function panel, measures substances in the blood that are linked to liver injury, bile flow, bilirubin handling, and protein production. The name can be slightly misleading because not every marker measures liver “function.” ALT and AST, for example, mainly show liver cell irritation or injury. Albumin and clotting tests are closer to true liver function because they reflect the liver’s ability to make proteins.
Most hepatic function panels include:
- ALT, or alanine aminotransferase
- AST, or aspartate aminotransferase
- ALP, or alkaline phosphatase
- Total bilirubin
- Direct bilirubin, in many panels
- Albumin
- Total protein
- Calculated globulin and albumin/globulin ratio, in some reports
Some liver panels also include GGT, but many laboratories order it separately. GGT is often used when ALP is high because ALP can come from the liver, bile ducts, bone, intestine, or placenta. A high ALP with a high GGT supports a liver or bile duct source. A high ALP with a normal GGT can point more toward bone or another non-liver source. For a deeper look at that distinction, see ALP and GGT patterns.
ALT is more concentrated in liver cells than AST, so it is often treated as the more liver-specific enzyme. AST is found in the liver but also in skeletal muscle, heart muscle, red blood cells, and other tissues. That is why an isolated AST elevation can happen after intense exercise, muscle injury, or hemolysis, not only from liver disease.
ALP and bilirubin tell a different story. ALP tends to rise when bile flow is slowed or blocked. Bilirubin rises when the body makes too much bilirubin, the liver cannot process it well, or bile cannot drain normally. Albumin and total protein help show whether the liver is making normal amounts of protein, but they are also affected by nutrition, inflammation, kidney disease, intestinal protein loss, hydration, and chronic illness.
A hepatic function panel is often ordered when someone has symptoms such as fatigue, nausea, itching, yellowing of the skin or eyes, abdominal swelling, right upper abdominal pain, dark urine, or pale stools. It is also used to monitor known liver disease, check medication side effects, evaluate alcohol-related risk, and follow abnormal results from a comprehensive metabolic panel.
Normal Ranges and What Counts as Abnormal
Normal ranges are not universal. They vary by laboratory, testing method, sex, age, pregnancy status, and sometimes body size or ancestry. The ranges below are common adult reference ranges, but the range printed on the actual lab report should guide interpretation.
| Marker | Common reference range | What it mainly reflects |
|---|---|---|
| ALT | About 7–56 U/L | Liver cell irritation or injury |
| AST | About 10–40 U/L | Liver, muscle, red blood cell, or other tissue injury |
| ALP | About 44–147 U/L | Bile duct, liver, bone, intestine, or placenta sources |
| Total bilirubin | About 0.1–1.2 mg/dL | Bilirubin production, liver processing, and bile drainage |
| Direct bilirubin | About 0.0–0.3 mg/dL | Conjugated bilirubin and bile drainage patterns |
| Albumin | About 3.5–5.0 g/dL | Protein production, nutrition, inflammation, kidney or gut loss |
| Total protein | About 6.0–8.3 g/dL | Albumin plus globulins |
| A/G ratio | Often about 1.0–2.2 | Balance between albumin and globulins |
A result just outside the reference range is not always a sign of disease. Mild ALT or AST elevations can occur after viral illness, alcohol intake, strenuous exercise, weight gain, fatty liver disease, or medication changes. A mildly high bilirubin with normal liver enzymes can occur with Gilbert syndrome, a common inherited condition that affects bilirubin handling and often becomes more noticeable during fasting, illness, dehydration, or stress.
The size of the abnormality matters. A result that is one to two times the upper limit of normal is different from a result that is 10, 20, or 50 times the upper limit. ALT and AST in the hundreds may suggest active liver inflammation or injury. ALT and AST above 1,000 U/L can occur with acute viral hepatitis, severe drug-induced liver injury, ischemic liver injury from poor blood flow, or acetaminophen toxicity. Those levels usually need fast medical evaluation, especially if bilirubin or INR is also abnormal.
Trends are often more useful than one snapshot. A single abnormal test can improve on repeat testing. A rising bilirubin, falling albumin, increasing INR, or persistently high enzymes usually deserves more attention than one mild, isolated abnormality.
How to Read Liver Enzyme Patterns
The hepatic function panel becomes more useful when the results are read as a pattern. Doctors often group liver test patterns into hepatocellular, cholestatic, mixed, and isolated bilirubin patterns.
A hepatocellular pattern means ALT and AST are higher than expected compared with ALP. This pattern points toward irritation or injury of liver cells. Common causes include fatty liver disease, viral hepatitis, alcohol-related liver injury, autoimmune hepatitis, medication injury, supplement injury, ischemic hepatitis, and some inherited liver diseases. The relationship between ALT and AST can add context, and ALT and AST interpretation is often most helpful when both values are compared with ALP, bilirubin, symptoms, and medication history.
A cholestatic pattern means ALP and often bilirubin are higher than expected compared with ALT and AST. Cholestasis means bile is not flowing normally. This can happen inside the liver, as with certain medications, primary biliary cholangitis, primary sclerosing cholangitis, pregnancy-related cholestasis, infiltrative disease, or severe hepatitis. It can also happen outside the liver, such as from gallstones, bile duct narrowing, pancreatic disease, or tumors pressing on bile ducts.
A mixed pattern includes both liver cell injury and impaired bile flow. Drug-induced liver injury, viral hepatitis, alcohol-related liver disease, gallstone disease, and autoimmune liver disease can all produce mixed patterns.
An isolated bilirubin pattern means bilirubin is high while ALT, AST, and ALP are normal or near normal. This pattern has a different set of possibilities. Indirect bilirubin may rise with Gilbert syndrome or increased red blood cell breakdown. Direct bilirubin may rise from inherited bilirubin transport conditions or early bile flow problems. When bilirubin is abnormal, separating direct from indirect bilirubin can clarify the next step; direct and indirect bilirubin patterns are often more informative than total bilirubin alone.
Some reports use an R ratio to classify patterns, especially when drug-induced liver injury is possible. The formula compares ALT elevation with ALP elevation, using each lab’s upper limit of normal. An R ratio above 5 suggests a hepatocellular pattern, below 2 suggests a cholestatic pattern, and 2 to 5 suggests a mixed pattern. Most patients do not need to calculate this themselves, but the concept explains why doctors look at relative elevations rather than isolated numbers.
Bilirubin, Albumin, and Protein Results
Bilirubin is a yellow pigment made when the body breaks down old red blood cells. The liver takes indirect bilirubin from the blood, converts it into a water-soluble form called direct or conjugated bilirubin, and sends it into bile. Bile then flows through the bile ducts into the intestine.
High bilirubin can cause jaundice, which means yellowing of the skin or whites of the eyes. It can also cause dark urine when direct bilirubin spills into urine. Pale or clay-colored stools can occur when bile is not reaching the intestine well. Itching can occur when bile flow is impaired, although itching severity does not always match the bilirubin number.
A bilirubin pattern can point in different directions:
- High indirect bilirubin can occur with Gilbert syndrome, fasting, dehydration, illness, heavy exertion, or increased red blood cell breakdown.
- High direct bilirubin can occur when liver cells cannot move bilirubin into bile properly or when bile drainage is blocked.
- High bilirubin with high ALP often raises concern for cholestasis or bile duct obstruction.
- High bilirubin with very high ALT and AST can occur with acute hepatitis or serious liver cell injury.
When bilirubin and liver enzymes are both abnormal, the relationship between them helps separate liver inflammation, bile duct disease, and red blood cell breakdown. A focused discussion of bilirubin and liver enzyme patterns can help make sense of jaundice-related results.
Albumin is a major blood protein made by the liver. It helps keep fluid inside blood vessels and carries hormones, medications, fatty acids, and other substances through the bloodstream. Low albumin can occur in advanced chronic liver disease because the liver may lose some ability to make protein. But low albumin is not specific to liver disease. It can also happen with kidney protein loss, intestinal protein loss, inflammation, burns, severe infection, cancer, malnutrition, or major fluid overload.
Albumin changes slowly because it has a relatively long half-life. It is not usually the first marker to fall in a short illness. A low albumin level is more concerning when it appears with other signs of reduced liver function, such as a high INR, low platelets, fluid in the abdomen, or imaging findings of cirrhosis. The combination of albumin and INR gives a clearer view of liver synthetic function than albumin alone.
Total protein includes albumin plus globulins. Globulins include antibodies and other proteins related to immune activity and inflammation. A high total protein can occur with dehydration or high globulins. A low total protein can occur with malnutrition, liver disease, kidney loss, or intestinal protein loss. The A/G ratio compares albumin with globulins. A low A/G ratio can occur when albumin is low, globulins are high, or both.
Common Causes of Abnormal Results
Abnormal hepatic function panel results can come from liver disease, bile duct disease, medications, alcohol, metabolic conditions, muscle injury, blood cell breakdown, or temporary stress on the body. The panel points toward possibilities; it does not name the cause by itself.
Metabolic dysfunction-associated steatotic liver disease, often called fatty liver disease, is one of the most common reasons for mildly high ALT or AST. It is more likely in people with insulin resistance, type 2 diabetes, high triglycerides, larger waist size, high blood pressure, or sleep apnea. ALT is often higher than AST early on, but AST can become equal to or higher than ALT when advanced scarring develops.
Alcohol-related liver injury can raise AST, ALT, GGT, bilirubin, or INR. In many alcohol-related patterns, AST is higher than ALT, sometimes with an AST/ALT ratio above 2. This pattern is not perfect and should not be used as a stand-alone diagnosis. GGT can rise with alcohol use but also with many medications and other liver conditions. For a more focused pattern, see AST/ALT ratio and GGT interpretation.
Viral hepatitis can cause mild, moderate, or very high ALT and AST. Hepatitis A, B, C, E, Epstein-Barr virus, cytomegalovirus, and other infections can affect liver tests. Acute viral hepatitis may produce ALT and AST in the hundreds or thousands, sometimes with jaundice.
Medication and supplement injury is another major category. Acetaminophen overdose can cause severe liver injury and very high aminotransferases. Other medications, including some antibiotics, seizure medicines, statins, antifungals, tuberculosis medicines, immune therapies, and herbal or bodybuilding supplements, can also affect liver tests. A careful medication and supplement list is essential because “natural” products can still injure the liver.
Gallstones and bile duct obstruction often cause high ALP, high direct bilirubin, dark urine, pale stools, itching, or right upper abdominal pain. If fever and chills occur with jaundice and abdominal pain, infection in the bile ducts becomes a concern and needs urgent evaluation.
Autoimmune and inherited liver diseases can also change the panel. Autoimmune hepatitis, primary biliary cholangitis, primary sclerosing cholangitis, hemochromatosis, Wilson disease, and alpha-1 antitrypsin deficiency are examples. The likelihood depends on age, symptoms, family history, other autoimmune disease, iron studies, copper studies, antibody tests, and imaging.
Non-liver causes deserve attention too. AST can rise from muscle injury, intense workouts, seizures, heart injury, or hemolysis. ALP can rise from bone growth, bone healing, vitamin D deficiency, Paget disease, pregnancy, or some cancers. Bilirubin can rise from increased red blood cell breakdown. This is why abnormal liver tests may be followed by CK, GGT, hepatitis testing, iron studies, blood counts, ultrasound, or other targeted tests.
Preparation, Repeat Testing, and Follow-Up
Many hepatic function panels are done with a routine blood draw. Some clinicians ask for fasting if the panel is being drawn with cholesterol, glucose, insulin, or other metabolic tests. Fasting is not always required for liver markers alone, but following the lab’s instructions matters.
Before testing, it helps to tell the clinician about:
- Prescription medications
- Over-the-counter medicines, especially acetaminophen
- Vitamins, minerals, herbs, teas, and bodybuilding supplements
- Alcohol intake, including recent heavier-than-usual drinking
- Recent intense exercise or muscle injury
- Recent viral illness, vomiting, dehydration, or fever
- Pregnancy or recent delivery
- Known gallstones, hepatitis exposure, or liver disease
Do not stop prescribed medicine on your own before the test unless your clinician tells you to. Stopping some medicines abruptly can be dangerous. If a medicine may be affecting the liver, the decision to pause, switch, reduce, or continue it depends on the degree of abnormality and the reason the medicine is being used.
Follow-up depends on the pattern and severity. A mild isolated ALT or AST elevation may be repeated in a few weeks after avoiding alcohol, reviewing medications, and allowing recovery from illness or hard exercise. Persistent elevations often lead to additional testing. This may include hepatitis B and C testing, iron studies, autoimmune markers, metabolic risk assessment, ultrasound, fibrosis scores, or specialist referral.
A high ALP is often followed by GGT or 5′-nucleotidase to help confirm whether the source is liver or bone. If a liver or bile duct source is likely, ultrasound is commonly used to look for bile duct dilation, gallstones, liver texture changes, masses, or signs of chronic liver disease.
When fatty liver disease is suspected, clinicians may calculate noninvasive fibrosis scores such as FIB-4 or APRI. These scores use routine blood tests to estimate the chance of significant liver scarring. They do not replace a full clinical evaluation, but they help decide who may need elastography, imaging, or hepatology referral. A comparison of FIB-4 and APRI can clarify why platelet count, AST, ALT, and age are often reviewed together.
Repeat testing should be purposeful. Repeating the same panel without reviewing causes may only delay the next step. The best follow-up usually combines trend monitoring with a targeted search for the cause.
When Results Need Urgent Care
Some hepatic function panel results can wait for routine follow-up. Others need urgent attention, especially when abnormal numbers appear with symptoms of liver failure, bile duct infection, severe hepatitis, or medication toxicity.
Seek urgent medical care if liver test abnormalities occur with:
- Yellow skin or yellow eyes that are new or worsening
- Confusion, severe sleepiness, personality changes, or trouble staying awake
- Vomiting that will not stop or inability to keep fluids down
- Severe pain in the right upper abdomen, especially with fever
- Dark urine with pale stools
- Easy bruising, bleeding, black stools, or vomiting blood
- Swollen abdomen, new leg swelling, or shortness of breath
- Fainting, severe weakness, or signs of dehydration
- Suspected acetaminophen overdose or toxic ingestion
The combination of high ALT or AST with high bilirubin can be more concerning than enzyme elevation alone. High INR, if measured, is especially important because it can reflect reduced production of clotting factors. In acute liver injury, a rising INR can signal severe disease even before albumin changes.
Very high ALT and AST, especially above 1,000 U/L, often need fast evaluation. Possible causes include acetaminophen toxicity, acute viral hepatitis, ischemic hepatitis, severe drug-induced liver injury, autoimmune hepatitis, and acute bile duct obstruction in some cases. The exact cause cannot be assumed from the panel alone.
Jaundice with fever and abdominal pain can suggest cholangitis, an infection related to blocked bile ducts. This is a medical emergency. Jaundice with confusion can suggest severe liver dysfunction and also needs immediate care.
A person taking warfarin, chemotherapy, immune therapy, tuberculosis medication, seizure medication, or high-dose acetaminophen should contact a clinician quickly if liver tests become abnormal. The same is true for people with known cirrhosis, chronic hepatitis B or C, autoimmune liver disease, or prior drug-induced liver injury.
How the Panel Fits With Other Liver Tests
A hepatic function panel is a starting point, not the whole liver evaluation. It shows biochemical patterns in the blood. It does not directly show liver stiffness, fat content, bile duct anatomy, portal pressure, or microscopic inflammation and scarring.
A clinician may add tests based on the pattern:
| Finding | Possible next tests | Reason |
|---|---|---|
| High ALT or AST | Hepatitis tests, medication review, CK, iron studies, autoimmune markers | Looks for liver inflammation, muscle injury, iron overload, or immune causes |
| High ALP | GGT, 5′-nucleotidase, vitamin D, bone tests, ultrasound | Helps separate liver, bile duct, and bone sources |
| High bilirubin | Direct bilirubin, CBC, reticulocyte count, haptoglobin, ultrasound | Helps separate hemolysis, bilirubin processing problems, and obstruction |
| Low albumin | Urine protein, kidney tests, inflammatory markers, INR, nutrition review | Checks liver production and non-liver causes of protein loss |
| Possible fibrosis risk | Platelets, FIB-4, APRI, elastography, ultrasound | Estimates liver scarring risk without immediate biopsy |
Imaging is often used when ALP or bilirubin is high, when pain suggests gallbladder disease, or when chronic liver disease is possible. Ultrasound is common because it can show gallstones, bile duct dilation, liver texture, fluid in the abdomen, and some masses. Elastography measures liver stiffness and helps estimate scarring. MRI or CT may be used when ultrasound is unclear or when a more detailed view is needed.
A liver biopsy is less common than it used to be, but it still has a role when blood tests and imaging cannot answer the question. It can show inflammation, fat, fibrosis stage, autoimmune patterns, iron deposition, copper-related changes, bile duct injury, or drug-related patterns.
The hepatic function panel also overlaps with broader liver testing. A liver function tests panel may include GGT, PT/INR, or other markers depending on the lab and clinical setting. A coagulation panel may be added when bleeding risk or synthetic function is a concern; PT, INR, and aPTT interpretation is especially relevant when advanced liver disease or acute liver failure is possible.
The most useful interpretation combines the panel with timing. A sudden spike after a new medication, a slow rise over years with metabolic risk factors, a cholestatic pattern with pain after meals, and a low albumin with swelling all suggest different next steps. The numbers matter, but the story around the numbers often matters just as much.
References
- Liver Function Tests 2023 (Official Patient Resource)
- Liver Function Tests 2023 (Review)
- AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease 2023 (Guideline)
- AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury 2023 (Guideline)
- EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis – 2021 update 2021 (Guideline)
Disclaimer
A hepatic function panel can show important liver and bile duct patterns, but it cannot diagnose a specific condition without clinical context. Normal and abnormal ranges vary by laboratory, and some abnormal results come from non-liver causes such as muscle injury, bone disease, kidney disease, inflammation, or medication effects. Discuss abnormal results with a qualified healthcare professional, especially if symptoms, pregnancy, known liver disease, heavy alcohol use, or medication toxicity may be involved.
